| Name | Title | Contact Details |
|---|
Wondr Health™ is a digital behavioral change program focused on weight management that helps participants improve their physical and mental wellbeing through simple, interactive, and clinically-proven skills and tools. By treating the root cause of obesity through behavioral science, Wondr reduces risk factors to prevent chronic diseases like diabetes and hypertension, helps enhance employee productivity and engagement, decreases claims costs, and improves overall wellbeing. Wondr Health`s team of renowned doctors and scientists teaches practical, data-backed skills that empower participants to stress less, sleep better, and feel better. The highly personalized program has helped hundreds of thousands of people by teaching employees the science of eating the foods they love so they can still lose weight—regardless of their food preferences, background, or lifestyle, Wondr works for everyone. We`ve been in the benefits space for 15+ years and our clients include many Fortune 500 companies. We currently partner with over 800+ employers, brokers, health plans, and TPAs nationwide. We`ve cracked the code on the science behind improving the health of organizations—with the easiest implementation ever, third-party validated ROI, and clinical results you can count on—Wondr`s a benefit that actually benefits. We`re the ultimate “and” program—we don`t replace your diabetes management or sleep solution. Wondr can work alongside existing benefits as a standalone to enhance the impact of your other point solutions. Through the app, online community, certified coaches, and series of weekly videos that offer a new perspective on better health, participants enter a world where weight loss is a science, small steps lead to big changes, possibilities are infinite, and good habits last.
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.
Precision Medical Products is a Denver, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Interlace Medical, Inc. is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NavigatorMD, Inc. was founded in 2005 to address the rising demand for an integrated data analysis and health plan management solution. As an insurance broker, Ernest Youngblood, founder of NavigatorMD, watched the progressive increase in health care costs and identified the opportunity for organizations to save money while improving the overall wellness of a plan population. Youngblood led the organization of a multi-disciplinary team of healthcare professionals, ranging from physicians and pharmacologists to benefit consultants and C-Suite executives to develop its first product, Design180®. The intended purpose of this advisory team was to establish an understanding of the problems and hurdles that faced the business community in managing and understanding their health claims spend. This unique insight and knowledge was the basis of its technically sound, business-oriented approach to claims analysis and comprehensive health plan management. NavigatorMD launched its first product in 2008 with the mission of lowering health care costs and adding value to health plans by focusing on manageable costs and utilizing the power of data. Influenced by the concept of value-based insurance design, our health claims data analytics software was created under the advisory of various professionals, including former VP of Strategic H.R. Initiatives at Pitney Bowes, David Hom, who served as an early member of the NavigatorMD's Board of Directors. Early success and escalating interest in the product resulted in the formation of an advisory board comprising several influential experts in the field of Value-Based Insurance Design (VBID). In addition, NavigatorMD received support and referrals from two of the largest pharmaceutical companies in the U.S. that were responsible for funding the development of the Center for Value Based Health Management, among other value-based health care initiatives. NavigatorMD, the first step toward proactive health plan management.